A Study of LY2157299 in Participants With Advanced Hepatocellular Carcinoma

Clinical trial NCT02178358 · COMPLETED

Trial details

NCT number: NCT02178358
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2014-08-08
Primary completion: 2017-06-30
Enrollment: 132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.